Lazaro Rondy Michael, Smith Joshua M, Bender Nicholas, Punreddy Ankit, Barford Nathan, Paul Jennifer H
Department of Physical Medicine and Rehabilitation, University of Rochester Medical Center, Rochester, NY.
Lifespan Physician Group, Department of Neurology, Warren Alpert Medical School at Brown University, Providence, RI; and.
Clin J Sport Med. 2024 Jul 24;35(5):543-548. doi: 10.1097/JSM.0000000000001260.
To compare pain levels of intra-articular hip steroid injections performed with and without prior subcutaneous local anesthesia (LA) injection.
Randomized prospective study.
University-based musculoskeletal clinic.
Forty-one adult patients undergoing a first-time ultrasound-guided unilateral intra-articular hip steroid injection.
Subjects were randomized into 1 of 2 groups: intra-articular hip injection with prior subcutaneous LA with 2 mL of lidocaine 1% (With LA) or hip injection without prior subcutaneous LA (Without LA). Visual analog scale (VAS) pain scores (0-100) were collected before and after each injection.
Visual analog scale pain score for the intra-articular hip injection.
Of the 41 total subjects, 18 were randomized to the Without LA group and 23 to the With LA group. There was no significant difference in baseline (preprocedure) VAS scores between the Without LA (mean ± SD = 39.2 ± 27.2) and With LA (41.2 ± 24.0) groups ( P = 0.864). The mean ± SD VAS score for the subcutaneous LA injection in the With LA group was 20.4 ± 16.1. There was no significant difference in VAS scores for the intra-articular hip injection between the Without LA (48.5 ± 27.7) and With LA (39.5 ± 25.7) groups ( P = 0.232).
Subcutaneous injection of lidocaine before an intra-articular hip injection did not significantly decrease pain from the intra-articular hip injection. Providers may perform intra-articular hip injections with a 22-gauge 3.5-inch spinal needle without the need for an extra subcutaneous LA injection.
比较在进行髋关节腔内类固醇注射时，预先进行皮下局部麻醉（LA）注射与不进行该注射时的疼痛程度。
随机前瞻性研究。
大学附属的肌肉骨骼诊所。
41名首次接受超声引导下单侧髋关节腔内类固醇注射的成年患者。
将受试者随机分为2组中的1组：预先皮下注射2毫升1%利多卡因进行髋关节腔内注射（有LA组）或不预先进行皮下LA注射的髋关节注射（无LA组）。在每次注射前后收集视觉模拟量表（VAS）疼痛评分（0 - 100）。
髋关节腔内注射的视觉模拟量表疼痛评分。
在41名受试者中，18人被随机分配到无LA组，23人被分配到有LA组。无LA组（均值±标准差 = 39.2 ± 27.2）和有LA组（41.2 ± 24.0）的基线（术前）VAS评分无显著差异（P = 0.864）。有LA组皮下LA注射的平均±标准差VAS评分为20.4 ± 16.1。无LA组（48.5 ± 27.7）和有LA组（39.5 ± 25.7）髋关节腔内注射的VAS评分无显著差异（P = 0.232）。
在髋关节腔内注射前皮下注射利多卡因并不能显著减轻髋关节腔内注射带来的疼痛。医护人员可以使用22号3.5英寸的脊椎穿刺针进行髋关节腔内注射，无需额外进行皮下LA注射。
